Q2 2025 earnings reveal mixed results for U.S. property & casualty insurers, highlighting key drivers like underwriting margins, catastrophe losses, and interest rates impacting revenue and stock performance.

F&G Annuities & Life attracts institutional investors with strong Q2 earnings and steady dividends, reflecting confidence in its insurance and annuity products.

Institutional investors including Wellington Management and Raymond James increase holdings in F&G Annuities & Life after the insurer reports strong quarterly earnings and raises dividend payout.

Q2 earnings for leading U.S. insurance companies reveal mixed financial results amid stable market conditions and evolving underwriting and investment dynamics. Key players like Kemper, Root, Selective, Travelers, and CNA highlight trends in revenue growth, EPS performance, and stock movements.

Cognizant's strong Q1 2025 earnings boost its market value, underpinning growth in technology services for insurance and healthcare sectors.

F&G Annuities & Life reports missed Q1 2025 earnings and downward revisions to full-year revenue and earnings forecasts amid market uncertainties.

Travelers reports strong Q2 2025 results with improved underwriting discipline, premium growth, and strategic capital deployment, poised to outperform peers in the U.S. insurance market.

Morgan Stanley downgrades Progressive citing valuation pressures and competitive challenges in the U.S. auto insurance sector, impacting growth and market outlook.

UnitedHealthcare’s Q1 2025 earnings saw a market overreaction due to increased Medicare Advantage costs and CEO resignation. Despite short-term guidance reductions, strong profitability and diversified revenue streams make it a compelling value opportunity.

UnitedHealth Group's CEO responds to Q1 earnings miss driven by Medicare Advantage medical cost surges and DOJ scrutiny, outlining reforms to manage rising care expenses and rebuild investor confidence.